Carolyn D. Britten, MD
Location: Hollings Cancer Center 380A
Carolyn D. Britten, MD, is Chief of the Division of Hematology/Oncology, Department of Medicine at MUSC, and holds an endowed chair supported by the South Carolina SmartState Center of Excellence in Gastrointestinal Malignancies.
She trained in medical oncology at the University of British Columbia in Vancouver, Canada, and completed a two-year clinical research fellowship in Phase I clinical trials at the Institute for Drug Development in San Antonio, Texas. As a faculty member at the University of California, Los Angeles (UCLA) for 11 years, she developed the solid tumor Phase I clinical trials program. While at UCLA, she received an NCI-Avon Progress for Patients Award, during which time Dr. Dennis Slamon mentored her in translational research. At UCLA’s Jonsson Comprehensive Cancer Center, she was Co-Associate Leader of the Signal Transduction and Therapeutics Program and Director of the Protocol-Specific Research Support Unit for their long-standing CCSG. She has served on the American Society of Clinical Oncology’s Program and Education Committees.